12.02.2018 11:31:00

GlaxoSmithKline plc -- Moody's: M&A greatest downside risk to European pharma companies' credit quality in 2018

Announcement: Moody's: M&A greatest downside risk to European pharma companies' credit quality in 2018

Vollständigen Artikel bei Moodys lesen